TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact SueWallSt
Executive Accountability: Chief Medical Officer Stuart Rich is named in the Tenax securities action over his alleged assurances that the Phase 3 LEVEL study of TNX-103 was enriched with the patients most likely to respond. NEW YORK, Oct. 29, 2026 /PRNewswire/ -- SueWallSt notifies...
Covered in this story
Call it yourself
No calls on $TENX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tenax Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.